跳轉至內容
Merck
  • A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

Journal of the American Chemical Society (2012-12-18)
Laura Bertolacci, Elisa Romeo, Marina Veronesi, Paola Magotti, Clara Albani, Mauro Dionisi, Chiara Lambruschini, Rita Scarpelli, Andrea Cavalli, Marco De Vivo, Daniele Piomelli, Gianpiero Garau
摘要

In addition to inhibiting the cyclooxygenase (COX)-mediated biosynthesis of prostanoids, various widely used nonsteroidal anti-inflammatory drugs (NSAIDs) enhance endocannabinoid signaling by blocking the anandamide-degrading membrane enzyme fatty acid amide hydrolase (FAAH). The X-ray structure of FAAH in complex with the NSAID carprofen, along with site-directed mutagenesis, enzyme activity assays, and NMR analysis, has revealed the molecular details of this interaction, providing information that may guide the design of dual FAAH-COX inhibitors with superior analgesic efficacy.

材料
產品編號
品牌
產品描述

Supelco
卡洛芬, VETRANAL®, analytical standard